Keywords
Ventricular septal defect closure, congenital heart disease, Powerbreath medic plus, threshold IMT, maximal inspiratory pressure, functional capacity.
This article is included in the Datta Meghe Institute of Higher Education and Research collection.
Ventricular septal defect closure, congenital heart disease, Powerbreath medic plus, threshold IMT, maximal inspiratory pressure, functional capacity.
Congenital heart diseases (CHDs), one of the most frequent foetal defects, can occur in as many as 13 out of every 1000 live births.1 CHDs are among the most prevalent foetal malformations. The most frequent acynotic congenital cardiac abnormalities in children are ventricular septal defects (VSD), which are the second most common congenital anomaly in adults.1,2 Shunt formation and inappropriate right-to-left ventricular communication are the primary causes of hemodynamic compromise in VSD due to presence of aperture between the ventricles.3,4 Many VSDs close on their own, however if they fail to, large defects can cause a number of problems, including pulmonary arterial hypertension (PAH), ventricular dysfunction, and a greater incidence of arrhythmias. If there are significant problems, the most common procedure in paediatric cardiac surgery is surgical closure of the ventricular septal defect.3,5–7
Transient diaphragm dysfunction is reportedly frequent in the initial week following cardiac surgery, based on numerous studies.8,9 In patients receiving elective heart surgery, the prevalence of residual diaphragm dysfunction was 8%, and it was linked to poor respiratory outcomes.9,10 Several pulmonary complications, such as collapse of the lung, collection of fluid in pleura, pneumonia, cardiogenic pulmonary oedema, acute respiratory distress syndrome, pulmonary embolism, phrenic nerve injury, pneumothorax, sternal wound infection and inflamation as well as longer hospital stays and prolonged ventilator support, are caused by diaphragmatic dysfunction.8–12 Furthermore, cardiac procedures impair breathing mechanics, decrease lung volume, obstruct gas exchange, affect the ventilation-to-perfusion ratio, lung capacities, and promote physical inactivity, all of which lower functional capacity.13,14
Early ambulation and mobility, breathing exercises, coughing techniques, incentive spirometers, and strengthening of respiratory musculature are all cardiopulmonary physical therapy interventions that have been documented to be beneficial for lowering the occurrence of pulmonary problems.15 Patients having heart operations have shown possible positive effects from inspiratory muscle training (IMT).15 Numerous IMT devices are utilised to prevent diaphragmatic dysfunction and respiratory issues.15 Research on the application of Powerbreathe training and enhancing maximal inspiratory pressure in individuals who underwent VSD closure is scant. Data on physical therapy interventions and results in individuals who had VSD closure surgery are rare.
IMT improves the capacity for functional activity as well as respiratory muscle strength. The two main categories of IMT equipment are devices with pressure- and volume-based loading.16,17 A pressure-based threshold device called Power Breathe (PwB) limits airflow during inspiration until it achieves a particular pressure. This inspiratory pressure is modifiable by adjusting the spring tension to match the patient’s maximal inspiratory pressure (MIP). The lineal resistance to the flow increment must be as low as possible when the pressure is surpassed and the valve is opened. Due to coupled action of respiratory musculature and the PwB device, higher lung charges of between 186 and 274 centimetres of water (cmH2O) pressure can be produced.18,19 The most popular inspiratory muscle trainer for improvising the power and endurance of the respiratory musculature is the Threshold IMT, a pressure-based loading apparatus. It can provide resistance up to 41 cm H2O and hence retraining the inspiratory muscles at different resistance levels.17
This article presents the protocol for the full study, whose objective is to assess and evaluate the effectiveness of the PowerBrethe medic plus device and the threshold IMT device in patients who underwent VSD closure in a two-arm parallel superiority/equivalence randomised control trial (RCT). The end point results will be compared on a marginal basis to determine effectiveness.
1. To assess and evaluate the subjects who underwent VSD closure, intervened with Power Breathe Medic Plus adjunct to conservative physiotherapy management and its effect on improving maximal inspiratory pressure (Micro Respiratory Pressure Meter) and functional capacity (6 Minute Walk Distance Test) in the entire populace.
2. To assess and evaluate the subjects who underwent VSD closure for the change in pulmonary function parameters (FEV1, FVC AND FEV1/FVC ratio) treated with Power Breathe Medic Plus adjunct to conservative physiotherapy management, to observe if it can improve pulmonary functioning in the entire populace.
3. To analyse the efficacy over the treatment of Power Breathe Medic Plus along with conventional physiotherapy management and Threshold IMT along with conventional physiotherapy management for bringing on change in maximal inspiratory pressure and functional capacity for the patients who underwent VSD closure.
This protocol has been registered with CTRI (CTRI/2023/03/051090) on 27/03/2023.
This study will be conducted with written informed consent from all participants. Ethical approval was received from the institutional ethics committee (ref: DMIHER (DU)/IEC/2023/545) on 04/02/23.
Single centric, two arm parallel equivalence randomized controlled trial. Participants in the study will be split into two groups. Group-A (Powerbreath and conservative physiotherapy management) and Group-B (Threshold IMT and conservative physiotherapy management) by randomization for 1:1 allocation with intent to treat purpose.
Participants will be chosen from the Cardiovascular and Thoracic Surgery Unit at Acharya Vinobha Bhave Hospital Sawangi in Meghe, Wardha, Maharashtra, following approval from the institutional ethics committee of Datta Meghe Institute of Higher Education and Research. Potential participants will be identified through their medical records and evaluation. The participants will be screened as per inclusion and exclusion criteria followed by randomization using a computer-generated list. Allocation will be done by sequentially numbered opaque sealed envelopes. Allocation and participant enrolment will be done by the primary investigator. The therapist will be aware of the allocations. The inclusion and exclusion criteria for selection will be based on the cut-off values at baseline parameters when engaging participants. Throughout the six-month recruitment phase, a second source of recruitment will be used if more study participants are needed; this will be an additional local private hospital.
To compare improvements in maximal inspiratory pressure and functional capacity at the end point, the interventional group will receive Powerbreath and conservative physiotherapy management (Figure 1), and the control group will receive Threshold IMT and conservative physiotherapy management (Figure 1). Participants will be enrolled and evaluated at several intervals, including first visit and second visit for subject enrolment and screening respectively, baseline, 4 weeks, and 2 weeks after treatment for follow-up, when primary and secondary parameters will be measured. The study design is depicted in Figure 1.
After screening and randomization, the experimental group will receive inspiratory muscle training with PowerBreathe along with conservative physiotherapy management (Table 1) which will start from post-operative day 3 (POD-3). The training will be delivered in-person at the hospital. Initially the postoperative training will begin with 40% of the preoperative MIP recorded, and weekly load increases of 5–10% will be made based on the patient’s tolerability. The patient will obtain postoperative training for 20 to 30 minutes per session, which will consist of six sets of five deep breathes against the trainer device, with only a brief rest period of 1 to 2 minutes in between each set. Training will be done twice a day, every day, for four weeks.20 The treatment will be discontinued or modified if patient is not willing to continue or faces any discomfort. To improve adherence to the treatment, counselling sessions will be arranged for patient and his/her family on how this device can be useful to improve lung function post-operatively along with various other medical interventions.
After screening and randomization, the control group will receive inspiratory muscle training with Threshold IMT along with conservative physiotherapy management (Table 1) which will start from POD-3. The training will be delivered in-person at the hospital. Initially, the postoperative training will be 40% of the MIP that was observed pre-operatively, followed by an increase in load by 5–10% per week based on the tolerance of the patient. The patient will get postoperative training for 20 to 30 minutes per session, which will consist of six sets of five deep breaths against the trainer device, with only a brief rest period of 1 to 2 minutes in between each set. Training will be done twice a day, every day for four weeks.13 The treatment will be discontinued or modified if patient is not willing to continue or faces any discomfort. To improve adherence to the treatment, counselling sessions will be arranged for patient and his/her family on how this device can be useful to improve lung function post-operatively along with various other medical interventions.
Primary outcomes
• Change in maximal inspiratory pressure and MicroRPM reading (respiratory pressure meter).
MicroRPM demonstrated excellent inter-rater reliability for inspiratory pressure and good inter-rater reliability for expiratory pressure, as well as strong contemporaneous validity and test-retest reliability. In reference to concurrent validity for inspiratory and expiratory pressures, the intraclass correlation coefficientS (ICC) were 0.77 and 0.86, respectively. Inter-rater reliability revealed ICCs as 0.91 for inspiratory pressure and 0.84 for expiratory pressure, with test-retest reliability demonstrating an ICC of 0.87 for inspiratory pressure and 0.78 for expiratory pressure.21
• Change in 6 MWD (Minute Walk distance) Test.
The 6MWD is a submaximal exercise test that is quick and easy to administer and is well-tolerated by the patient. With an ICC of 0.90, it is a standardized field test to assess functional capacity after exercise performance in people with a range of cardiac and pulmonary problems.22,23
Secondary outcomes
• Change in Pulmonary Function Test (PFT).
The simplest and most practical pulmonary function test (PFT) is spirometry, which measures air exhaled or inhaled during forceful movements. It is a quantifiable, repeatable, non-invasive, and comparatively easy technique for determining lung function. FEV1, FVC and FEV1/FVC ratio will be collected.24
Safety outcomes
Adverse events will be reported at each time. No adverse effects are anticipated.
Sample size calculation resulted at 5% level of significance considering both the sides at 5% error probability with total 10 % for Z(1-α) value =1.64 & (1- β) at power of 80 % = 0.84 measuring the mean difference (effect size) of = 10.3 & standard deviation ( = 15.75
Sample size calculation formula using mean difference:
Primary variable (maximum inspiratory pressure)
Mean ± SD (pre) result on maximum inspiratory pressure for conventional chest therapy (control group) = 103 ±15
Mean ± SD (post) result on maximum inspiratory pressure for conventional chest therapy (control group) = 113.3 ±16.5
As per reference article.25
Considering 10% drop out = 2
Total samples required (n1 =n2 = 30 per Group)
Total sample size required (N) = 2*30 = 60
Assumptions
Reference article: Inspiratory muscle training and functional capacity following coronary artery bypass grafting in high-risk patients: A pilot randomized and controlled trial.25
Data collection, management and analysis.
All the results will be calculated using R studio software 4.3. Demographic variables as per the quantitative assessment will be nanalysed for the mean±SD and the frequency and percentage. Inferential statistic data with the variables will be tested for the normality using the Kolmogorov-Smirnov Test. A parametric test will be used if data follows normal distribution. The paired-t test will be used for pre- and post-analysis. Alternatively, the Wilcoxon Test will be used as a non-parametric test if the data are not normally distributed. Similarly, for the unpaired-t test, the Mann Whitney test will be used as an alternative. Association analysis for finding significance of cofounding parameters will be evaluated by using the Chi-squared test or Fisher’s exact test or by using multi-variant analysis. Sensitivity and specificity of the device will be tested over primary outcome (MIP). AUC (area under curve) will be calculated on the basis of observational values for finding accuracy of the device.
Inferential statistics will be utilized to compare the two groups for their mean change in primary variable (MicroRPM and 6MWD Test) between baseline, 4 weeks and follow up after 2 weeks using the linear mixed model. The two groups will be active treatment versus control treatment. The participants’ responses will be evaluated in light of the major variable’s variation from baseline to the timeline measured during the study (visit 1 and after the conclusion of 4 weeks, and follow-up after 2 weeks after the conclusion of the intervention). For research participants, random effects will be generalised, and treatment group and visit count will be taken into consideration while analysing fixed effects. With a corresponding 95% confidence interval (CI), the effect size over the mean change difference on the major variable from baseline to end line visit at 4 weeks and 2 weeks follow up will be measured.
In order to forecast the difference in impact size between the active and control groups, secondary outcomes (PFT) will be examined according to the aforementioned linear mixed model effect. If the data has a normal distribution, the t-test (unpaired) will be used to determine whether there is a significant difference between the means in comparison between the two groups. For non-normal distribution, the translation of the data to the normal distribution will be done using MATHEMATICAL algorithms. The alternative non-parametric tests (Chi square, Mann Whitney, and Wilcoxon tests) will be used if the data across the major variable still exhibit non-normal distribution.
CHDs, specifically VSD, are commonly encountered condition in children as well as adults which, if they fail to close on their own, require open heart surgery for the closure of the defect.1 Cardiac surgeries are used worldwide for treatment of patients with such heart conditions, and rates of post-operative complications are still significant, mainly involving pulmonary complications.3,5 This study’s objective is to assess and evaluate the effectiveness of the PowerBrethe medic plus device and the Threshold IMT device in patients who underwent VSD closure. The end point results will be compared on a marginal basis to determine effectiveness.
In their non-blinded randomised controlled experiment, Rhoia Neidenbach et al. (2023) reported that the effects of IMT on lung capacity and exercise capacity were assessed in a sizable cohort of 40 Fontan patients. They discovered a noticeably better oxygen saturation, which is a clinically meaningful improvement.26 In a randomised controlled trial conducted by Fatma A. Hegazy et al. in 2021, 100 patients who had undergone mitral valve replacement surgery participated. The researchers looked at the impact of postoperative high load, long duration inspiratory muscle training on pulmonary function and functional capacity using the Threshold IMT device. They discovered significant improvement in all measures (p 0.001) in the between-group study, and significant improvements in lung function, inspiratory pressure, and functional capacity (p 0.05) were found in the experimental group.13 In order to assess the effect of an inspiratory muscle strengthening programme using the PowerBreathe device on the ergogenic potential for respiratory and/or athletic performance, Diego Fernández-Lázaro et al. (2021) conducted a systemic review with meta-analysis. They came to the conclusion that the programme increased VO2 max, inspiratory muscle strength, pulmonary function, and sport performance.19 According to previous studies, training of inspiratory musculature is probably beneficial in increasing respiratory muscle strength, decreasing airway closure, and possibly even in enhancing breathing mechanics and lowering exercise-related dyspnea.27 These mechanistic alterations reflect the developing understanding of the function of inspiratory training in paediatric patients and can be used to explain improvements in symptomology and clinical outcomes.27
No data are associated with this protocol.
SPIRIT checklist for ‘Effect of Powerbreath Medic Plus versus Threshold IMT on maximal inspiratory pressure and functional capacity in post-operative ventricular septal defect closure: A randomized controlled trial’, https://doi.org/10.5281/zenodo.7988644. 28
I would like to acknowledge Mr. Laxmikant Umate and Mr. Manoj Patil who have helped me in sample size calculation and data analysis planning.
Views | Downloads | |
---|---|---|
F1000Research | - | - |
PubMed Central
Data from PMC are received and updated monthly.
|
- | - |
Is the rationale for, and objectives of, the study clearly described?
Partly
Is the study design appropriate for the research question?
No
Are sufficient details of the methods provided to allow replication by others?
No
Are the datasets clearly presented in a useable and accessible format?
Not applicable
References
1. Yau DKW, Underwood MJ, Joynt GM, Lee A: Effect of preparative rehabilitation on recovery after cardiac surgery: A systematic review.Ann Phys Rehabil Med. 2021; 64 (2): 101391 PubMed Abstract | Publisher Full TextCompeting Interests: No competing interests were disclosed.
Reviewer Expertise: Critical care; acute care; rehabilitation; physical therapy; respiratory care
Alongside their report, reviewers assign a status to the article:
Invited Reviewers | |
---|---|
1 | |
Version 1 07 Aug 23 |
read |
Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list:
Sign up for content alerts and receive a weekly or monthly email with all newly published articles
Already registered? Sign in
The email address should be the one you originally registered with F1000.
You registered with F1000 via Google, so we cannot reset your password.
To sign in, please click here.
If you still need help with your Google account password, please click here.
You registered with F1000 via Facebook, so we cannot reset your password.
To sign in, please click here.
If you still need help with your Facebook account password, please click here.
If your email address is registered with us, we will email you instructions to reset your password.
If you think you should have received this email but it has not arrived, please check your spam filters and/or contact for further assistance.
Comments on this article Comments (0)